Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-58.29	216.46	518.99
Graham Fair Price	326.10	1.58	0.37
PEG	-99.71	0.08	-26.99
Price/Book	-1.14	1.06	1.07
Price/Cash Flow	-581.30	-52.42	-7.69
Prices/Earnings	-94.96	135.73	2693.32
Price/Sales	-14.05	10.69	12.44
Price/FCF	-581.30	-52.42	-7.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	38.79	0.23	0.17
Operating Margin	34072.55	0.04	< 0.005
ROA	1813.35	< 0.005	< 0.005
ROE	< 0.005	< 0.005	1861.68
ROIC	< 0.005	< 0.005	20843.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.06	-0.02	169.24
Dividends QOQ	0.09	3.82	4316.58
EBIT QOQ	1.00	379.15	37821.40
EPS QOQ	-1.00	17.37	1641.07
FCF QOQ	-1.97	0.86	-56.24
Revenue QOQ	-0.23	0.11	-52.72
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3050.31	3052.67	0.08
Days Sales Outstanding (DSO)	258.76	255.81	-1.14
Inventory Turnover	0.03	0.03	-0.08
Debt/Capitalization	0.52	0.52	0.68
Quick Ratio	0.36	0.31	-11.67
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	7.82	7.58	-3.07
Cash	3.94	3.16	-19.66
Capex	< 0.005	< 0.005	34.04
Free Cash Flow	-1.09	-0.15	86.04
Revenue	0.67	0.75	10.66
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.52	1.45	-4.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	181.26	90.63	-50.00
Naive Interpretation	Member

06 - Financial Health · Weak

Rating